Cervical cancer affects the lives of 500,000 women worldwide each year, resulting in more than 270,000 deaths annually. Because the majority of cases occur in low-income countries that cannot afford the tools commonly used in the United States, new solutions must be found.
The key innovation that will help us achieve our goal is a product called the Callascope.
learn more about the Callascope. >>Equivalent to that of the most expensive colposcopes
Requires no invasive or uncomfortable speculum.
Created to overcome global accessibility needs at a sustainable cost.
Simplified means of performing a cervical exam
About 1/10 the cost of tradtional colposcopes
Option to collect patient data in form of cervical images. An opportunity for aggregation of data on disease prevalence.
Lightweight and easy to transport. Paired with mobile screen
Allows for remote diagnostics and EMR data collection
The speculum is one barrier to cervical cancer screening due to fear of pain, discomfort and embarrassment, particularly for women who have never been previously screened in a routine gynecological exam. The Callascope, an alternative to the standard speculum enables speculum-free, provider insertion or self-insertion, and image capture of the cervix.
learn more about the callascope >>The inserter is created without any moving parts and has a tip that resembles the shape of a Calla Lily and a stem for a slimmer version of the Pocket Colposcope. A smart phone with live video can guide the Callascope to the cervix. The Callascope with or without self-HPV testing can enable women to have complete control over the screening process.
The inserter is created without any moving parts and has a tip that resembles the shape of a Calla Lily and a stem for a slimmer version of the Pocket Colposcope. A smart phone with live video can guide the Callascope to the cervix. The Callascope with or without self-HPV testing can enable women to have complete control over the screening process.
learn more about the callascope >>In clinical investigations in over 8 countries across 4 continents. The Pocket Colposcope received FDA clearance in September 2018.
Press & User Reviews
“It is small, transportable, practical, it doesn’t require additional resources, you can use it in a mobile clinic."
It takes high quality images, and this really stood out to us.
It is small, transpotable, practical, it doesn’t require additional resources, you can use it in a mobile clinic.
The callascope comes in very handy to augment cervical cancer screening.
I really liked the Callascope. I thought it was really easy to use.
Much better (than the speculum), I like it. I would like this new one every time
It was an empowering and intimate experience with myself
I am really excited about the algorithms and the difference they can make